
The use of the anti-HIV drug tenofovir during pregnancy does not affect birth weight or birth length, according to new research conducted as part of the Pediatric HIV/AIDS Cohort Study. The impetus for this study was that previous research in laboratory animals showed that exposure to tenofovir in the womb was associated with smaller birth size compared with animals not exposed to the drug.











